The Association of Cytomegalovirus and Allostatic Load by Country of Birth and Length of Time in the United States
Abstract
:1. Introduction
1.1. Cytomegalovirus Epidemiology and Diagnosis
1.2. Immigrant Health in the United States
1.3. Immigration and Cytomegalovirus
1.4. CMV Serostatus Association with Socioeconomic Factors
1.5. Allostatic Load
1.6. Study Objectives
2. Materials and Methods
2.1. Study Population
2.2. AL Index
2.3. Measurement of Study Variables
2.4. Description of Study Variables and Covariates
2.5. Statistical Analysis
3. Results
3.1. Summary Statistics of Key Study Variables
3.2. Correlation of CMV, AL, Biomarkers and Sociodemographic Factors
3.3. Logistic Regression Modeling
4. Discussion
4.1. Implications of Results
4.2. Limitations
4.3. Strengths
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Collins-McMillen, D.; Rak, M.; Buehler, J.C.; Igarashi-Hayes, S.; Kamil, J.P.; Moorman, N.J.; Goodrum, F. Alternative promoters drive human cytomegalovirus reactivation from latency. Proc. Natl. Acad. Sci. USA 2019, 116, 17492–17497. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Reeves, M.; Sinclair, J. Aspects of human cytomegalovirus latency and reactivation. In Human Cytomegalovirus; Springer: Berlin/Heidelberg, Germany, 2008; pp. 297–313. [Google Scholar]
- Sinclair, J. Human cytomegalovirus: Latency and reactivation in the myeloid lineage. J. Clin. Virol. 2008, 41, 180–185. [Google Scholar] [CrossRef] [PubMed]
- Fowler, K.B.; Ross, S.A.; Shimamura, M.; Ahmed, A.; Palmer, A.L.; Michaels, M.G.; Bernstein, D.I.; Sánchez, P.J.; Feja, K.N.; Stewart, A. Racial and ethnic differences in the prevalence of congenital cytomegalovirus infection. J. Pediatr. 2018, 200, 196.e191–201.e191. [Google Scholar] [CrossRef] [PubMed]
- Jahan, M. Laboratory diagnosis of CMV infection: A review. Bangladesh J. Med. Microbiol. 2010, 4, 39–44. [Google Scholar] [CrossRef] [Green Version]
- Razonable, R.R.; Humar, A. Cytomegalovirus in solid organ transplant recipients—Guidelines of the American Society of Transplantation Infectious Diseases Community of Practice. Clin. Transplant. 2019, 33, e13512. [Google Scholar] [CrossRef]
- Prakash, K.; Chandorkar, A.; Saharia, K.K. Utility of CMV-specific immune monitoring for the management of CMV in solid organ transplant recipients: A clinical update. Diagnostics 2021, 11, 875. [Google Scholar] [CrossRef]
- Basson, J.; Tardy, J.; Aymard, M. Pattern of anti-cytomegalovirus IgM antibodies determined by immunoblotting. Arch. Virol. 1989, 108, 259–270. [Google Scholar] [CrossRef] [PubMed]
- Nielsen, S.L.; Sörensen, I.; Andersen, H.K. Kinetics of specific immunoglobulins M, E, A, and G in congenital, primary, and secondary cytomegalovirus infection studied by antibody-capture enzyme-linked immunosorbent assay. J. Clin. Microbiol. 1988, 26, 654–661. [Google Scholar] [CrossRef]
- Markides, K.S.; Rote, S. The healthy immigrant effect and aging in the United States and other western countries. Gerontologist 2019, 59, 205–214. [Google Scholar] [CrossRef] [Green Version]
- Dowd, J.B.; Aiello, A.E.; Alley, D.E. Socioeconomic disparities in the seroprevalence of cytomegalovirus infection in the US population: NHANES III. Epidemiol. Infect. 2009, 137, 58–65. [Google Scholar] [CrossRef] [Green Version]
- Cannon, M.J.; Schmid, D.S.; Hyde, T.B. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev. Med. Virol. 2010, 20, 202–213. [Google Scholar] [CrossRef]
- Staras, S.A.; Dollard, S.C.; Radford, K.W.; Flanders, W.D.; Pass, R.F.; Cannon, M.J. Seroprevalence of cytomegalovirus infection in the United States, 1988–1994. Clin. Infect. Dis. 2006, 43, 1143–1151. [Google Scholar] [CrossRef] [PubMed]
- Feinstein, L.; Douglas, C.E.; Stebbins, R.C.; Pawelec, G.; Simanek, A.M.; Aiello, A.E. Does cytomegalovirus infection contribute to socioeconomic disparities in all-cause mortality? Mech. Ageing Dev. 2016, 158, 53–61. [Google Scholar] [CrossRef] [Green Version]
- Dowd, J.B.; Haan, M.N.; Blythe, L.; Moore, K.; Aiello, A.E. Socioeconomic gradients in immune response to latent infection. Am. J. Epidemiol. 2008, 167, 112–120. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Guidi, J.; Lucente, M.; Sonino, N.; Fava, G.A. Allostatic load and its impact on health: A systematic review. Psychother. Psychosom. 2021, 90, 11–27. [Google Scholar] [CrossRef]
- Sterling, P. Principles of Allostasis: Optimal Design, Predictive Regulation, Pathophysiology, and Rational Therapeutics; Cambridge University Press: Cambridge, UK, 2004. [Google Scholar]
- Siew, R.V.K.; Nabe-Nielsen, K.; Turner, A.I.; Bujtor, M.; Torres, S.J. The role of combined modifiable lifestyle behaviors in the association between exposure to stressors and allostatic load: A systematic review of observational studies. Psychoneuroendocrinology 2022, 138, 105668. [Google Scholar] [CrossRef]
- Theall, B.; Wang, H.; Kuremsky, C.A.; Cho, E.; Hardin, K.; Robelot, L.; Marucci, J.; Mullenix, S.; Lemoine, N., Jr.; Johannsen, N.M. Allostatic stress load and CMV serostatus impact immune response to maximal exercise in collegiate swimmers. J. Appl. Physiol. 2020, 128, 178–188. [Google Scholar] [CrossRef] [PubMed]
- Dai, S.; Mo, Y.; Wang, Y.; Xiang, B.; Liao, Q.; Zhou, M.; Li, X.; Li, Y.; Xiong, W.; Li, G. Chronic stress promotes cancer development. Front. Oncol. 2020, 10, 1492. [Google Scholar] [CrossRef]
- McEwen, B.S. Protection and damage from acute and chronic stress: Allostasis and allostatic overload and relevance to the pathophysiology of psychiatric disorders. Ann. N. Y. Acad. Sci. 2004, 1032, 1–7. [Google Scholar] [CrossRef]
- Bahreinian, S.; Ball, G.D.C.; Leek, T.K.V.; Colman, I.; McNeil, B.J.; Becker, A.B.; Kozyrskyj, A.L. Allostatic Load Biomarkers and Asthma in Adolescents. Am. J. Respir. Crit. Care Med. 2013, 187, 144–152. [Google Scholar] [CrossRef]
- Duong, M.T.; Bingham, B.A.; Aldana, P.C.; Chung, S.T.; Sumner, A.E. Variation in the Calculation of Allostatic Load Score: 21 Examples from NHANES. J. Racial Ethn. Health Disparities 2017, 4, 455–461. [Google Scholar] [CrossRef] [PubMed]
- Petrovic, D.; Pivin, E.; Ponte, B.; Dhayat, N.; Pruijm, M.; Ehret, G.; Ackermann, D.; Guessous, I.; Younes, S.E.; Pechère-Bertschi, A.; et al. Sociodemographic, behavioral and genetic determinants of allostatic load in a Swiss population-based study. Psychoneuroendocrinology 2016, 67, 76–85. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rainisch, B.K.W.; Upchurch, D.M. Sociodemographic Correlates of Allostatic Load Among a National Sample of Adolescents: Findings From the National Health and Nutrition Examination Survey, 1999–2008. J. Adolesc. Health 2013, 53, 506–511. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Geronimus, A.T.; Hicken, M.; Keene, D.; Bound, J. “Weathering” and age patterns of allostatic load scores among blacks and whites in the United States. Am. J. Public Health 2006, 96, 826–833. [Google Scholar] [CrossRef] [PubMed]
- Hill, M.; Obeng-Gyasi, E. The Association of Cytomegalovirus IgM and Allostatic Load. Diseases 2022, 10, 70. [Google Scholar] [CrossRef] [PubMed]
- R Development Core Team. R: A Language and Environment for Statistical Computing; R Foundation for Statistical Computing: Vienna, Austria, 2022. [Google Scholar]
- Reed, R.G.; Presnell, S.R.; Al-Attar, A.; Lutz, C.T.; Segerstrom, S.C. Perceived stress, cytomegalovirus titers, and late-differentiated T and NK cells: Between-, within-person associations in a longitudinal study of older adults. Brain Behav. Immun. 2019, 80, 266–274. [Google Scholar] [CrossRef]
- Crimmins, E.M.; Johnston, M.; Hayward, M.; Seeman, T. Age differences in allostatic load: An index of physiological dysregulation. Exp. Gerontol. 2003, 38, 731–734. [Google Scholar] [CrossRef]
- Kaestner, R.; Pearson, J.A.; Keene, D.; Geronimus, A.T. Stress, Allostatic Load, and Health of Mexican Immigrants. Soc. Sci. Q. 2009, 90, 1089–1111. [Google Scholar] [CrossRef]
- Taylor, J.; McFarland, M.J.; Carr, D.C. Age, Perceptions of Mattering, and Allostatic Load. J. Aging Health 2019, 31, 1830–1849. [Google Scholar] [CrossRef]
- Gruenewald, T.L.; Seeman, T.E.; Karlamangla, A.S.; Sarkisian, C.A. Allostatic load and frailty in older adults. J. Am. Geriatr. Soc. 2009, 57, 1525–1531. [Google Scholar] [CrossRef] [Green Version]
- Juster, R.-P.; Pruessner, J.C.; Desrochers, A.B.; Bourdon, O.; Durand, N.; Wan, N.; Tourjman, V.; Kouassi, E.; Lesage, A.; Lupien, S.J. Sex and gender roles in relation to mental health and allostatic load. Psychosom. Med. 2016, 78, 788–804. [Google Scholar] [CrossRef] [Green Version]
- Remes, O.; Brayne, C.; Van Der Linde, R.; Lafortune, L. A systematic review of reviews on the prevalence of anxiety disorders in adult populations. Brain Behav. 2016, 6, e00497. [Google Scholar] [CrossRef]
- Kerr, P.; Kheloui, S.; Rossi, M.; Désilets, M.; Juster, R.-P. Allostatic load and women’s brain health: A systematic review. Front. Neuroendocrinol. 2020, 59, 100858. [Google Scholar] [CrossRef] [PubMed]
- Obeng-Gyasi, E.; Obeng-Gyasi, B. Chronic stress and cardiovascular disease among individuals exposed to lead: A pilot study. Diseases 2020, 8, 7. [Google Scholar] [CrossRef] [Green Version]
- Hecker, M.; Qiu, D.; Marquardt, K.; Bein, G.; Hackstein, H. Continuous cytomegalovirus seroconversion in a large group of healthy blood donors. Vox Sang. 2004, 86, 41–44. [Google Scholar] [CrossRef] [PubMed]
- Adler, S. Cytomegalovirus and child day care: Evidence for an increased infection rate among day care workers. Pediatr. Infect. Dis. J. 1990, 9, 862. [Google Scholar] [CrossRef]
- Pass, R.F.; Hutto, C.; Lyon, M.D.; Cloud, G. Increased rate of cytomegalovirus infection among day care center workers. Pediatr. Infect. Dis. J. 1990, 9, 465–469. [Google Scholar] [CrossRef] [PubMed]
- Misra, M.K.; Mishra, A.; Pandey, S.K.; Kapoor, R.; Sharma, R.K.; Agrawal, S. Genetic variation in micro-RNA genes of host genome affects clinical manifestation of symptomatic human cytomegalovirus infection. Hum. Immunol. 2015, 76, 765–769. [Google Scholar] [CrossRef]
- Goldeck, D.; Larsen, L.A.; Christiansen, L.; Christensen, K.; Hamprecht, K.; Pawelec, G.; Derhovanessian, E. Genetic influence on the peripheral blood CD4+ T-cell differentiation status in CMV infection. J. Gerontol. Ser. A Biomed. Sci. Med. Sci. 2016, 71, 1537–1543. [Google Scholar] [CrossRef] [Green Version]
- Duchowny, K.A.; Noppert, G.A. The Association Between Cytomegalovirus and Disability by Race/Ethnicity and Sex: Results From the Health and Retirement Study. Am. J. Epidemiol. 2021, 190, 2314–2322. [Google Scholar] [CrossRef]
- Zhen, J.; Zeng, M.; Zheng, X.; Qiu, H.; Cheung, B.M.Y.; Xu, A.; Wu, J.; Li, C. Human cytomegalovirus infection is associated with stroke in women: The US National Health and Nutrition Examination Survey 1999–2004. Postgrad. Med. J. 2022, 98, 172–176. [Google Scholar] [CrossRef] [PubMed]
- Al-Attar, A.; Presnell, S.R.; Peterson, C.A.; Thomas, D.T.; Lutz, C.T. Data correlations between gender, cytomegalovirus infection and T cells, NK cells, and soluble immune mediators in elderly humans. Data Brief 2016, 8, 536–544. [Google Scholar] [CrossRef] [Green Version]
- Hyde, T.B.; Schmid, D.S.; Cannon, M.J. Cytomegalovirus seroconversion rates and risk factors: Implications for congenital CMV. Rev. Med. Virol. 2010, 20, 311–326. [Google Scholar] [CrossRef] [PubMed]
- Colugnati, F.A.; Staras, S.A.; Dollard, S.C.; Cannon, M.J. Incidence of cytomegalovirus infection among the general population and pregnant women in the United States. BMC Infect. Dis. 2007, 7, 71. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Fowler, K.B.; Stagno, S.; Pass, R.F. Interval between births and risk of congenital cytomegalovirus infection. Clin. Infect. Dis. 2004, 38, 1035–1037. [Google Scholar] [CrossRef]
- Leruez-Ville, M.; Guilleminot, T.; Stirnemann, J.; Salomon, L.J.; Spaggiari, E.; Faure-Bardon, V.; Magny, J.-F.; Ville, Y. Quantifying the burden of congenital cytomegalovirus infection with long-term sequelae in subsequent pregnancies of women seronegative at their first pregnancy. Clin. Infect. Dis. 2020, 71, 1598–1603. [Google Scholar] [CrossRef] [PubMed]
- Ikawa, H.; Hayashi, Y.; Ohbayashi, C.; Tankawa, H.; Itoh, H. Autopsy case of alcoholic hepatitis and cirrhosis treated with corticosteroids and affected by Pneumocystis carinii and cytomegalovirus pneumonia. Pathol. Int. 2001, 51, 629–632. [Google Scholar] [CrossRef]
- Glaser, R.; Kiecolt-Glaser, J. Stress damages immune system and health. Discov. Med. 2009, 5, 165–169. [Google Scholar]
- Barnett, E.D.; Walker, P.F. Role of Immigrants and Migrants in Emerging Infectious Diseases. Med. Clin. N. Am. 2008, 92, 1447–1458. [Google Scholar] [CrossRef]
CMV IgG | ||||
---|---|---|---|---|
Characteristic | Overall, N = 124,348,343 | Negative, n = 57,026,831 (45.86%) | Positive, n = 67,321,512 (54.14%) | p-Value |
Age, years (SE) | 34.81 (0.21) | 34.31 (0.30) | 35.23 (0.25) | 0.011 |
Sex | <0.001 | |||
Female | 50.84% | 39.92% | 60.08% | |
Male | 49.16% | 52.01% | 47.99% | |
Race/Ethnicity | <0.001 | |||
NH White people | 67.16% | 57.85% | 42.15% | |
Mexican American | 9.90% | 16.20% | 83.80% | |
NH Black people | 12.41% | 21.33% | 78.67% | |
Other and/or Multi-racial | 5.29% | 22.49% | 77.51% | |
Other Hispanic | 5.24% | 29.95% | 70.05% | |
Poverty Line ($20,000) | <0.001 | |||
Above | 74.26% | 49.51% | 50.49% | |
At or Below | 23.64% | 34.58% | 65.42% | |
Education Level | <0.001 | |||
College graduate or above | 24.46% | 60.91% | 39.09% | |
Some college or AA degree | 32.72% | 47.61% | 52.39% | |
High school graduate/GED or equivalent | 26.43% | 43.19% | 56.81% | |
9–11th grade (includes 12th grade with no diploma) | 12.01% | 28.72% | 71.28% | |
Less than 9th grade | 4.31% | 11.34% | 88.66% | |
Alcohol Consumption | <0.001 | |||
Yes | 35.70% | 48.55% | 51.45% | |
No | 11.28% | 35.49% | 64.51% | |
Currently Smoking | 0.200 | |||
Yes | 30.22% | 44.23% | 55.77% | |
No | 16.82% | 47.58% | 52.42% | |
Muscle Strengthening Activities | <0.001 | |||
Yes | 32.69% | 52.84% | 47.16% | |
No | 66.15% | 42.34% | 57.66% | |
Unable to Do | 1.15% | 49.88% | 50.12% | |
Birth Country | <0.001 | |||
Born in US | 83.62% | 51.87% | 48.13% | |
Born in Mexico | 6.42% | 7.83% | 92.17% | |
Born elsewhere (Not US nor Mexico) | 9.97% | 19.90% | 80.10% | |
Time in US | <0.001 | |||
20 or more years | 87.60% | 50.37% | 49.63% | |
Less than 20 years | 12.29% | 13.95% | 86.05% | |
SBP average reported to examinee | 116.33 (0.33) | 116.29 (0.53) | 116.36 (0.35) | 0.500 |
DBP average reported to examinee | 71.56 (0.27) | 71.43 (0.36) | 71.67 (0.35) | 0.700 |
HDL-cholesterol (mg/dL) | 50.61 (0.30) | 50.87 (0.58) | 50.40 (0.36) | 0.700 |
Total cholesterol (mg/dL) | 196.62 (0.78) | 195.89 (1.24) | 197.24 (1.00) | 0.300 |
Triglycerides (mg/dL) | 141.24 (4.11) | 145.15 (6.08) | 137.96 (5.32) | 0.400 |
Glycohemoglobin (%) | 5.33 (0.01) | 5.28 (0.02) | 5.36 (0.02) | <0.001 |
Albumin, urine (ug/mL) | 22.47 (2.53) | 21.26 (4.15) | 23.50 (2.73) | <0.001 |
Body Mass Index (kg/m2) | 27.86 (0.12) | 27.62 (0.18) | 28.07 (0.17) | 0.023 |
Creatinine, urine (mg/dL) | 140.46 (2.56) | 136.72 (2.93) | 143.62 (3.03) | 0.045 |
C-reactive protein(mg/dL) | 0.39 (0.01) | 0.35 (0.01) | 0.43 (0.02) | 0.012 |
AL Index | 2.53 (0.08) | 2.55 (0.10) | 2.52 (0.14) | >0.900 |
AL Risk | 0.600 | |||
High | 10.92% | 42.58% | 57.42% | |
Low | 12.46% | 45.02% | 54.98% |
AL | ||||
---|---|---|---|---|
Characteristic | Overall, N = 29,114,886 | Low, n = 15,491,141 (53.21%) | High, n = 13,623,745 (46.79%) | p-Value |
Age (years) | 34.60 (0.39) | 32.18 (0.53) | 37.35 (0.46) | <0.001 |
Sex | <0.001 | |||
Female | 48.59% | 59.70% | 40.30% | |
Male | 51.41% | 47.07% | 52.93% | |
Race/Ethnicity | 0.500 | |||
NH White | 66.70% | 53.22% | 46.78% | |
Mexican American | 9.97% | 59.65% | 40.35% | |
NH Black people | 13.28% | 51.86% | 48.14% | |
Other and/or Multi-racial | 5.27% | 51.79% | 48.21% | |
Other Hispanic | 4.78% | 44.87% | 55.13% | |
Poverty Line ($20,000) | 0.200 | |||
Above | 74.51% | 51.36% | 48.64% | |
At or Below | 23.66% | 59.75% | 40.25% | |
Education Level | 0.200 | |||
College graduate or above | 20.33% | 52.88% | 47.12% | |
Some college or AA degree | 34.68% | 56.40% | 43.60% | |
High school graduate/GED or equivalent | 27.44% | 54.76% | 45.24% | |
9–11th grade (includes 12th grade with no diploma) | 12.05% | 45.29% | 54.71% | |
Less than 9th grade | 5.21% | 43.31% | 56.69% | |
Alcohol Consumption | 0.400 | |||
Yes | 72.79% | 53.81% | 46.19% | |
No | 23.36% | 49.73% | 50.27% | |
Currently Smoking | 0.600 | |||
Yes | 29.22% | 51.23% | 48.77% | |
No | 16.65% | 47.14% | 52.86% | |
Muscle Strengthening Activities | 0.002 | |||
Yes | 32.59% | 65.48% | 34.52% | |
No | 66.68% | 47.41% | 52.59% | |
Unable to Do | 0.73% | 34.79% | 65.21% | |
Birth Country | 0.200 | |||
Born in US | 83.77% | 52.06% | 47.94% | |
Born elsewhere (Not US nor Mexico) | 9.24% | 58.43% | 41.57% | |
Born in Mexico | 6.99% | 60.05% | 39.95% | |
Time in US | 0.029 | |||
20 or more years | 88.29% | 52.01% | 47.99% | |
Less than 20 years | 11.57% | 62.99% | 37.01% | |
SBP average reported to examinee | 115.88 (0.51) | 111.10 (0.69) | 121.31 (0.85) | <0.001 |
DBP average reported to examinee | 72.39 (0.58) | 68.63 (0.67) | 76.67 (0.44) | <0.001 |
HDL-cholesterol (mg/dL) | 49.79 (0.45) | 53.34 (0.47) | 45.76 (0.75) | <0.001 |
Total cholesterol (mg/dL) | 194.05 (2.20) | 180.42 (2.01) | 209.56 (3.18) | <0.001 |
Triglycerides (mg/dL) | 141.23 (4.95) | 99.72 (4.41) | 188.42 (10.24) | <0.001 |
Glycohemoglobin (%) | 5.33 (0.02) | 5.17 (0.02) | 5.51 (0.04) | <0.001 |
Albumin, urine (ug/mL) | 34.78 (8.00) | 19.28 (5.59) | 52.40 (15.51) | 0.005 |
Body Mass Index (kg/m2) | 27.60 (0.18) | 25.12 (0.22) | 30.43 (0.39) | <0.001 |
Creatinine, urine (mg/dL) | 147.42 (3.59) | 154.95 (4.54) | 138.85 (4.09) | 0.004 |
C-reactive protein(mg/dL) | 0.35 (0.03) | 0.23 (0.03) | 0.48 (0.04) | <0.001 |
CMV IgG | 0.600 | |||
Negative | 43.82% | 54.67% | 45.33% | |
Positive | 56.04% | 52.20% | 47.80% |
CMV IgG | ||||||
---|---|---|---|---|---|---|
Born in the US | Born Outside the US | Overall | ||||
OR (2.5%, 97.5%) | p-Values | OR (2.5%, 97.5%) | p-Values | OR (2.5%, 97.5%) | p-Value | |
Age | 1.02 (0.98, 1.06) | 0.1980 | 1.04 (0.95, 1.13) | 0.6330 | 1.02 (0.99, 1.06) | 0.192 |
Sex | ||||||
Male | 0.49 (0.24, 0.98) | 0.0456 | 1.80 (0.46, 7.00) | 0.3500 | 0.48 (0.24, 0.94) | 0.036 |
Female | Reference | |||||
Alcohol Consumption | ||||||
Yes | 0.54 (0.21, 1.43) | 0.1848 | 0.06 (0.01, 0.78) | 0.0350 | 0.46 (0.16, 1.31) | 0.125 |
No | Reference | |||||
Currently Smoking | ||||||
Yes | 1.33 (0.76, 2.32) | 0.2693 | 2.48 (0.75, 8.21) | 0.1190 | 1.40 (0.84, 2.34) | 0.173 |
No | Reference | |||||
AL Risk | ||||||
High | 0.91 (0.50, 1.66) | 0.7211 | 1.10 (0.61, 2.00) | 0.714 | ||
Low | Reference | |||||
Poverty Line | ||||||
Above | 0.64 (0.33, 1.25) | 0.1645 | 0.68 (0.11, 4.10) | 0.6330 | ||
At or Below | Reference |
CMV IgG | ||||||
---|---|---|---|---|---|---|
Born in the US | Born Outside the US | Overall | ||||
OR (2.5%, 97.5%) | p-Values | OR (2.5%, 97.5%) | p-Values | OR (2.5%, 97.5%) | p-Value | |
Age | 1.02 (0.99, 1.06) | 0.1897 | 0.99 (0.89, 1.11) | 0.8991 | 1.02 (0.99, 1.06) | 0.173 |
Sex | ||||||
Male | 0.49 (0.25, 0.97) | 0.0424 | 0.75 (0.07, 8.55) | 0.7778 | 0.49 (0.25, 0.95) | 0.038 |
Female | Reference | |||||
Alcohol Consumption | ||||||
Yes | 0.45 (0.17, 1.24) | 0.1090 | 0.99 (0.08, 12.09) | 0.9887 | 0.45 (0.16, 1.29) | 0.118 |
No | Reference | |||||
Currently Smoking | ||||||
Yes | 1.44 (0.85, 2.45) | 0.1553 | 1.84 (0.29, 11.73) | 0.4358 | 1.39 (0.84, 2.32) | 0.172 |
No | Reference | |||||
AL Index | 0.96 (0.82, 1.12) | 0.5448 | 3.69 (1.75, 7.76) | 0.0063 | 1.00 (0.85, 1.18) | 0.992 |
Time in the US | ||||||
Less than 20 years | 0.33 (0.00, 27.34) | 0.5505 | ||||
20 or more years | Reference | |||||
Birth Country | ||||||
Born in Mexico | 20.62 (6.71, 63.36) | <0.001 | ||||
Born elsewhere (Not US nor Mexico) | 6.21 (1.54, 25.09) | 0.017 | ||||
Born in the US | Reference | |||||
Model AIC | 496.4671 | 59.3118 | 600.3614 |
AL | ||||
---|---|---|---|---|
Using Birth Country | Using Time in the US | |||
OR (2.5%, 97.5%) | p-Values | OR (2.5%, 97.5%) | p-Value | |
Age | 1.06 (1.03, 1.10) | 0.004 | 1.06 (1.02, 1.10) | 0.004 |
Sex | ||||
Male | 2.06 (1.30, 3.29) | 0.008 | 2.11 (1.35, 3.31) | 0.005 |
Female | Reference | |||
Alcohol Consumption | ||||
Yes | 0.45 (0.16, 1.27) | 0.110 | 0.45 (0.16, 1.27) | 0.114 |
No | Reference | |||
Currently Smoking | ||||
Yes | 0.86 (0.38, 1.98) | 0.689 | 0.86 (0.38, 1.94) | 0.686 |
No | Reference | |||
CMV IgG | ||||
Positive | 1.05 (0.55, 2.00) | 0.867 | 1.07 (0.57, 2.01) | 0.807 |
Negative | Reference | |||
Birth Country | ||||
Born in Mexico | 0.96 (0.43, 2.15) | 0.913 | ||
Born elsewhere (Not US nor Mexico) | 0.87 (0.42, 1.81) | 0.673 | ||
Born in US | Reference | |||
Poverty Line | ||||
Above | 0.87 (0.38, 1.98) | 0.702 | 0.84 (0.38, 1.86) | 0.631 |
At or Below | Reference | |||
Time in US | ||||
Less than 20 years | 0.70 (0.29, 1.67) | 0.375 | ||
20 or more years | Reference | |||
Model AIC | 616.4932 | 615.3074 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Hill, M.; Mostafa, S.; Muganda, P.M.; Jeffers-Francis, L.K.; Obeng-Gyasi, E. The Association of Cytomegalovirus and Allostatic Load by Country of Birth and Length of Time in the United States. Diseases 2023, 11, 101. https://doi.org/10.3390/diseases11030101
Hill M, Mostafa S, Muganda PM, Jeffers-Francis LK, Obeng-Gyasi E. The Association of Cytomegalovirus and Allostatic Load by Country of Birth and Length of Time in the United States. Diseases. 2023; 11(3):101. https://doi.org/10.3390/diseases11030101
Chicago/Turabian StyleHill, Matthew, Sayed Mostafa, Perpetua M. Muganda, Liesl K. Jeffers-Francis, and Emmanuel Obeng-Gyasi. 2023. "The Association of Cytomegalovirus and Allostatic Load by Country of Birth and Length of Time in the United States" Diseases 11, no. 3: 101. https://doi.org/10.3390/diseases11030101
APA StyleHill, M., Mostafa, S., Muganda, P. M., Jeffers-Francis, L. K., & Obeng-Gyasi, E. (2023). The Association of Cytomegalovirus and Allostatic Load by Country of Birth and Length of Time in the United States. Diseases, 11(3), 101. https://doi.org/10.3390/diseases11030101